Health Secretary Matt Hancock has said there is a “very strong argument” for making it compulsory for schoolchildren to be vaccinated.Read the full story ›
The vaccine was tested on 35 healthy women.Read the full story ›
The vaccine could prevent 64,138 cervical cancers and 49,649 non-cervical cancers in the UK by 2058, estimates suggest.Read the full story ›
A global survey of more than 140,000 people in more than 140 countries found 79% of the world’s population think vaccines are safe.Read the full story ›
The number of people who aren't being vaccinated against measles is on the rise. Here's a list of symptoms of the virus.Read the full story ›
A lifesaving vaccine against Meningitis B is set to be licensed for use in the UK in a move that could save thousands of lives.
The disease, which is the most common and deadliest form of meningitis in the country, affects an average of 1,870 people a year, many of them children, and results in death for one in 10 sufferers.
The approval of the new 4CMenB vaccine, which is developed by pharmaceutical company Novartis, has been hailed as the "biggest leap forward in the field in the three decades" by the charity Meningitis UK.